← FDA Drug Approvals (Drugs@FDA)

SUMATRIPTAN SUCCINATE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: CAPLIN · Approved 2021-07-13

Drug application

FDA Application #

ANDA213998

Application type

Abbreviated New Drug Application (Generic)

Brand name

SUMATRIPTAN SUCCINATE

Generic name

SUMATRIPTAN

Active ingredients

SUMATRIPTAN SUCCINATE

Dosage form

INJECTABLE

Route

SUBCUTANEOUS

Marketing status

Prescription

Sponsor

CAPLIN

Manufacturer

Somerset Therapeutics, LLC

First approval

2021-07-13

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown